|[January 31, 2014]
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Merge Healthcare, Incorporated to Contact Brower Piven Before the March 17, 2014 Lead Plaintiff Deadline
STEVENSON, Md. --(Business Wire)--
Brower Piven, A Professional Corporation announces that a class action
lawsuit has been commenced in the United States District Court for the
Northern District of Illinois on behalf of purchasers of Merge
Healthcare, Incorporated, ("Merge Healthcare (News - Alert)" or the "Company")
(NasdaqGS: MRGE) common stock during the period between August 1, 2012
and January 17, 2014, inclusive (the "Class Period").
If you are a shareholder who purchased Merge Healthcare common stock
during the Class Period, you may obtain additional information about
this lawsuit and your ability to become a lead plaintiff, at no cost to
you, by contacting Brower Piven at www.browerpiven.com,
by email at firstname.lastname@example.org,
by calling 410/415-6616, or at Brower Piven, A Professional Corporation,
1925 Old Valley Road, Stevenson Maryland 21153. Attorneys at Brower
Piven have combined experience litigating securities and class action
cases of over 60 years.
No class has yet been certified in the above action. Members of the
Class will be represented by the lead plaintiff and counsel chosen by
the lead plaintiff. If you wish to choose counsel to represent you and
the Class, you must apply to be appointed lead plaintiff no later than
March 17, 2014 and be selected by the Court. The lead plaintiff will
direct the litigation and participate in important decisions including
whether to accept a settlement and how much of a settlement to accept
for the Class in the action. The lead plaintiff will be selected from
among applicants claiming the largest loss from investment in Company
units during the Class Period.
The complaint accuses the defendants of violations of the Securities
Exchange Act of 1934 by virtue of the defendants' failure to disclose
during the Class Period that both the existence and value of millions of
dollars of the Company's eClinical customer contracts had been
falsified, and as a result the Company's reported subscription backlog
was overstated during the six quarters ended September 30, 2013, and
that the Company was experiencing a continued reluctance amongst large
health systems to move forward with enterprise imaging purchases.
According to the complaint, following the Company's disclosures in May
2013 regarding the sudden resignation of the Company's General Counsel
and later its Chairman and CEO, and the release of "very disappointing"
second quarter 2013 earnings results and a January 8, 2014 announcement
that the existence and/or value of millions of dollars of customer
contracts had been falsified for six quarters ending September 30,
2013, ending September 30, 2013, in what it characterized as a rogue
employee's attempt to reach sales quotas and garner additional
commissions, the value of Merge Healthcare shares declined significantly.
If you choose to retain counsel, you may retain Brower Piven without
financial obligation or cost to you, or you may retain other counsel of
your choice. You need take no action at this time to be a member of the
[ Back To TMCnet.com's Homepage ]